Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Vaccinex (VCNX)

Vaccinex Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VCNX
DateTimeSourceHeadlineSymbolCompany
17/12/202414:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
17/12/202414:00GlobeNewswire Inc.Vaccinex Announces Receipt of Delisting Notification from NasdaqNASDAQ:VCNXVaccinex Inc
18/11/202421:15Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:VCNXVaccinex Inc
18/11/202421:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCNXVaccinex Inc
18/11/202421:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCNXVaccinex Inc
18/11/202413:30GlobeNewswire Inc.Vaccinex Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:VCNXVaccinex Inc
14/11/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
14/11/202421:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VCNXVaccinex Inc
14/11/202420:39Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:VCNXVaccinex Inc
07/11/202413:30GlobeNewswire Inc.Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITCNASDAQ:VCNXVaccinex Inc
05/11/202413:30GlobeNewswire Inc.Vaccinex Reports Improved Immunity Correlating with Clinical Benefit of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer’s Annual MeetingNASDAQ:VCNXVaccinex Inc
31/10/202414:00GlobeNewswire Inc.Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference in Madrid, SpainNASDAQ:VCNXVaccinex Inc
25/10/202420:11Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VCNXVaccinex Inc
25/10/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VCNXVaccinex Inc
24/10/202412:30GlobeNewswire Inc.Vaccinex to Report Promising New Efficacy Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference on October 31, 2024NASDAQ:VCNXVaccinex Inc
16/10/202420:44Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:VCNXVaccinex Inc
09/10/202420:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
27/09/202420:11Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:VCNXVaccinex Inc
20/09/202421:15Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:VCNXVaccinex Inc
20/09/202420:57Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:VCNXVaccinex Inc
20/09/202420:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCNXVaccinex Inc
20/09/202420:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCNXVaccinex Inc
19/09/202412:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
18/09/202412:30GlobeNewswire Inc.Vaccinex Announces Exercise of Warrants for $6.2 Million in Gross ProceedsNASDAQ:VCNXVaccinex Inc
13/09/202420:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
20/08/202410:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
14/08/202421:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VCNXVaccinex Inc
14/08/202412:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
14/08/202412:30GlobeNewswire Inc.Vaccinex Provides Update on New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab in Alzheimer’s Disease and Plans to Pursue a Development PartnershipNASDAQ:VCNXVaccinex Inc
13/08/202420:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCNXVaccinex Inc
 Showing the most relevant articles for your search:NASDAQ:VCNX

Your Recent History